Margaret G. Lamb

Hematology | Oncology
700 Childrens Dr
Columbus, OH 43205

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

Journal: Blood cancer discovery
Published: May 18, 2026

Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

Journal: Research square
Published: February 23, 2026

Inclusion of Thiotepa in Myeloablative Regimens Improves Donor Chimerism in Children with Inborn Errors of Immunity or Inherited Metabolic Disorders.

Inclusion of Thiotepa in Myeloablative Regimens Improves Donor Chimerism in Children with Inborn Errors of Immunity or Inherited Metabolic Disorders.

Journal: British journal of haematology
Published: January 14, 2026

The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer.

The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer.

Journal: Nature reviews. Clinical oncology
Published: December 15, 2025

CAR T cell therapy for children with rheumatic disease: the time is now.

CAR T cell therapy for children with rheumatic disease: the time is now.

Journal: Nature reviews. Rheumatology
Published: May 28, 2025

Dark NKnight rising: a current perspective on NK cell and CAR-NK cell therapy.

Dark NKnight rising: a current perspective on NK cell and CAR-NK cell therapy.

Journal: Cytotherapy
Published: February 28, 2025

CAR T cell therapy for refractory pediatric systemic lupus erythematosus: a new era of hope?

CAR T cell therapy for refractory pediatric systemic lupus erythematosus: a new era of hope?

Journal: Pediatric rheumatology online journal
Published: March 18, 2024

Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual Meeting.

Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual Meeting.

Journal: Cytotherapy
Published: December 22, 2022

Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes.

Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes.

Journal: The Journal of infectious diseases
Published: August 15, 2022

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL).

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL).

Journal: Current treatment options in oncology
Published: October 11, 2021

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future.

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future.

Journal: Stem cell research & therapy
Published: January 05, 2021

COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients.

COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients.

Journal: The Journal of infection
Published: October 01, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026